Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Dosing in Morbidly Obese Patients
NCT01911520Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Jan 2011
- Primary completion
- Jun 2012
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Ghent University Hospital. Started Jan 2011; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT01911520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01911520.